Plasma kisspeptin levels in pregnancies with diabetes and hypertensive disease as a potential marker of placental dysfunction and adverse perinatal outcome

Endocrine Research

Volumn 37, Issue 2, 2012, Pages 78-88

  Ćetković, Aleksandar ^a   Miljic, Dragana ^a   Ljubić, Aleksandar ^a   Patterson, Michael ^a   Ghatei, Mohammad ^b   Stamenkoví, Jelena ^a   Nikolic Djurovic, Marina ^a   Pekic, Sandra ^a   Doknic, Mirjana ^a   Glišić, Andreja ^a   Bloom, Stephen ^b   Popovic, Vera ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

diabetes; hypertension; kisspeptin pregnancy; perinatal outcome; placental dysfunction; preeclampsia

Indexed keywords

KISSPEPTIN;

ADVERSE OUTCOME; AMNION FLUID; ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FETUS ECHOGRAPHY; FETUS MONITORING; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; OLIGOHYDRAMNIOS; OUTCOME ASSESSMENT; PERINATAL CARE; PLACENTA CIRCULATION; PLACENTA DISORDER; PLACENTA WEIGHT; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SECOND TRIMESTER PREGNANCY; SYSTOLIC BLOOD PRESSURE; THIRD TRIMESTER PREGNANCY; UMBILICAL ARTERY;

ADULT; DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPERTENSION; KISSPEPTINS; PLACENTA DISEASES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD;

EID: 84859588779     PISSN: 07435800     EISSN: 15324206     Source Type: Journal    
DOI: 10.3109/07435800.2011.639319     Document Type: Article

References (30)

1. Costa SL, Proctor L, Dodd JM, et al. Screening for placental insufficiency in high-risk pregnancies: Is earlier better? Placenta 2008;29:1034-1040.
2. Lee JH, Miele ME, Hicks DJ, et al. KiSS-1, a novel human malignant melanoma metastasissuppressor gene. J Natl Cancer Inst 1996;88:1731-1737. (Pubitemid 26405010)
3. Kotani M, Detheux M, Vandenbogaerde A, et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor G PR54. J Biol Chem 2001;276:34631-34636.
4. Ohtaki T, Shintani Y, Honda S, et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein coupled receptor. Nature 2001;411:613-617. (Pubitemid 32531412)
5. Muir AI, Chamberlain L, Elshourbagy NA, et al. AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem 2001;276:28969-28975.
6. Horikoshi Y, Matsumoto H, Takatsu Y, et al. Dramatic elevation of plasma metastin concentrations in human pregnancy:metastin as a novel placenta-derived hormone in humans. J Clin Endocrinol Metab 2003;88:914-919. (Pubitemid 36207842)
7. Janneau JL, Maldonado-Estrada J, Tachdjian G, et al. Transcriptional expression of genes involved in cell invasion and migration by normal and tumoral trophoblast cells. J Clin Endocrinol Metab 2002;87:5336-5339. (Pubitemid 35316382)
8. Bilban M, Ghaffari-Tabrizi N, Hintermann E, et al. Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts. J Cell Sci 2004;117:1319-1328. (Pubitemid 38559810)
9. Hiden U, Bilban M, Knofler M, Desoye G. Kisspeptins and the placenta: Regulation of trophoblast invasion. Rev EndocrMetab Disord 2007;8:31-39. (Pubitemid 46536847)
10. Suwaki N, Masuyama H, Masumoto A, Takamoto N, Hiramatsu Y. Expression and potential role of peroxisome proliferator-activated receptor y in the placenta of diabetic pregnancy. Placenta 2007;28:315-323. (Pubitemid 46505940)
11. Yang WC, Su TH, Yang YC, Chang SC, Chen CY, Chen CP. Altered perlecan expression in placental development and gestational diabetesmellitus. Placenta 2005;26:780-788.
12. Redman CW, Sargent IL. The pathogenesis of pre-eclampsia. Gynecol Obstet Fertil 2001;29:518-522. (Pubitemid 32861434)
13. Evers I, Nickels P, Sikkim J, Visser G. Placental pathology in women with type 1 diabetes and in a control group with normal and large-for-gestational- age infants. Placenta 2003;24:819-825. (Pubitemid 37184809)
14. Nelson S, Coan P, Burton G, Lindsay R. Placental structure in type 1 diabetes. Diabetes 2009;58:2634-2641.
15. Sibaia B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785-799. (Pubitemid 40311367)
16. Grill S, Rusterholz C, Zanetti-Dallenbach R, et al. Potential markers for preeclampsia-a review. Reprod Biol Endocrinol 2009;7:70-84.
17. Smets E, Deurloo K, Go A, Van Vugt J, Blankenstein M, Oudejans C. Decreased plasma levels of metastin in early pregnancy are associated with small for gestational age neonates. Prenat Diagn 2008;28:299-303. (Pubitemid 351519066)
18. Armstrong A, Reynolds R, Leask R, Shearing C, Calder A, Riley S. Decreased serum levels of kisspeptin in early pregnancy are associated with intra-uterine growth restriction and preeclampsia. Prenat Diagn 2009;29:982-985.
19. Lathi RB,Milki AA. Tissue sampling technique affects accuracy of karyotype from missed abortion. J Assist Reprod Genet 2002;19:536-538. (Pubitemid 35416740)
20. Gligorovic-Durutovic S. Neonatal Weight According to the Gestational Age at Delivery. 1st ed. Belgrade:Medical faculty of Belgrade; 2000:127-131.
21. Carpenter M, Coustain D. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768-773. (Pubitemid 13196587)
22. Toal M, Chan C, Fallah S, et al. Usefulness of a placental profile in high-risk pregnancies. Am J Gynecol Obstet 2007;196:1-7.
23. Dhillo WS, Chaudhri OB, Patterson M, et al. Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin EndocrinolMetab 2005;90:6609-6615. (Pubitemid 41759323)
24. Leach L, Taylor A, Sciota F. Vascular dysfunction in the diabetic placenta: Causes and consequences. J Anat 2009;215:69-76.
25. Farina A, Sekizawa A, Purwosunu Y, et al. Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls. Prenat Diagn 2006;26:1115-1120. (Pubitemid 44935273)
26. Qiao C,Wang CH, Shang T, Lin QD. Clinical significance of KiSS-1 and matrix metalloproteinase-9 expression in trophoblasts of women with preeclampsia and their relation to perinatal outcome of neonates. Zhonghua Fu Chan Ke Za Zhi 2005;40:585-590.
27. Dahlstrom B, Romunstatd P, Oian P, Vatten LJ, Eskild A. Placenta weight in pre-eclampsia. Acta Obstet Gynecol Scand 2008;87(6):608-611. (Pubitemid 351882480)
28. Zhong Y, Tuuli M, Odibo A. First-trimester assessment of placental function and the prediction of preeclampsia and intrauterine growth restriction. Prenat Diagn 2010;30:293-298.
29. Eskild A, Vatten LJ. Do pregnancies with pre-eclampsia have smaller placentas? A population study of 317 688 pregnancies with and without growth restriction in the offspring. BJOG 2010;117:1521-1526.
30. Nijher G, Chauddri O, Ramachandran R, et al. The effects of kisspeptin-54 on blood pressure in humans and plasma kisspeptin concentrations in hypertensive disease of pregnancy. Br J Clin Pharmacol 2010;70:674-681.